Total Funding
22
52
Total FundingSeed raised
Growth Score
-34 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
107825
We have developed a bioreactor technology that harnesses CO2 during operation and produces Wolffia, a high-quality, plant-based protein.
- Victor Vectorovich: Chief Technology Officer
About the Company
Biovolf is a biotech company. We have developed a fully automated sustainable bioreactor technology that produces high-quality plant-based protein from Wolffia and harnesses CO2 during operation. The advantages of our bioreactor solution are: • Operates 24/7; 365 days a year; • Suitable for any climate, provides a weekly harvest; •
Requiring only water and electricity to run. Biovolf’s technology is aimed at the 4 UN’s SDG Agenda Goals. Already raised $1,1M. HQ – Singapore; 2 branches in the UAE. Next round offer - $5M for 15% equity. Goal: 3x company valuation growth in 18 months Go-to-market strategy: Own production + TaaS scaling (royalty fees) Unit economics: Production cost $2/kg; market price: $4-35
